Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Refractive lens exchange with Oculentis multifocal intraocular lens implantation for moderate and high hyperopia

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Intraocular Refractive Results

Venue: Poster Village: Pod 2

First Author: : A.Ivashina RUSSIA

Co Author(s): :    N. Korshunova   M. Gulyaev   V. Malyshev        

Abstract Details

Purpose:

To evaluate the surgical outcomes and life quality of Refractive Lens Exchange with Oculentis IOL implantation for moderate and high Hyperopia.

Setting:

OKOMED Ophthalmic Clinic. Moscow. Russia.

Methods:

Clinical study included 87 eyes of 71 patients aged 13-76 years (mean 59.06±11.3) with Hyperopia from +3.0D to +12.0D (mean +8.75D). Mean axial length was 20.9±1.17mm (18.61- 22.9mm), lens thickness was 4.68±0.33mm (4.1-5.8mm). The mean keratometry was 43.58±1.45D. Phacoemulsification through 2.2 mm corneal incision with IOL Lentis Mplus LS-313 MF30 (Oculentis GmbH) implantation was performed. For calculation of IOL optical power we use IOL Master (Carl Zeiss Meditec). The IOL optical power was +25D to +35D. The follow-up period was 3 months to 1.5 years.

Results:

Before surgery BCDVA was <0.1 – 23.7%, 0.1-0.2 – 37.3%, 0.3-0.7 – 39.0% (mean 0.22±0.05). After surgery UDVA was 0.8-1.0 – 90.8%. Only 1 eye with amblyopia had 0.1(1.1%), and 0.6-0.7 had 7 eyes with glaucoma (8.1%). Stereo visual acuity (Fly-test) was 200 to 20 sec. 100% patients did not need spectacles for near distance. Mean BCNVA was 0.65±0.05.

Conclusions:

Refractive Lens Exchange with Lentis Mplus implantation is efficient for correction and life quality of patients with moderate and high Hyperopia.

Financial Disclosure:

NONE

Back to previous